Electrocardiographic electrode
Latest Warner-Lambert Company Patents:
- COMPOSITIONS OF ESSENTIALLY PURE FORM IV OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOF
- Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- METHODS OF TREATING NEUROFIBROMATOSIS WITH N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-BENZAMIDE
- Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
- Antibodies to M-CSF
Description
FIG. 1 is a top plan view of the electrocardiographic electrode embodying our new design;
FIG. 2 is a side elevational view thereof; and
FIG. 3 is a bottom plan view thereof with a portion of the rear backing peeled away.
Referenced Cited
Patent History
Patent number: D281012
Type: Grant
Filed: Sep 29, 1982
Date of Patent: Oct 15, 1985
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventors: Richard W. Beck (Centerville, OH), Kenneth R. Mandy (Sandy, UT), William G. Yates (Salt Lake City, UT)
Primary Examiner: James M. Gandy
Attorney: Louis S. Gillow
Application Number: 6/427,217
Type: Grant
Filed: Sep 29, 1982
Date of Patent: Oct 15, 1985
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventors: Richard W. Beck (Centerville, OH), Kenneth R. Mandy (Sandy, UT), William G. Yates (Salt Lake City, UT)
Primary Examiner: James M. Gandy
Attorney: Louis S. Gillow
Application Number: 6/427,217
Classifications
Current U.S. Class:
D24/29
